Suchergebnisse - "Wright, Emily K"

PubPharm (59)

11

The Effect of In Utero Exposure to Maternal Inflammatory Bowel Disease and Immunomodulators on Infant Immune System Development and Function

enthalten in: Cellular and molecular gastroenterology and hepatology | 2023

von Prentice, R. | Wright, E. | Flanagan, E. | +6

12

Gastrointestinal Involvement of Eosinophilic Granulomatosis with Polyangiitis with Histological Evidence of Treatment Response

enthalten in: Case reports in gastroenterology | 2023

von Lai, M. | He, T. | Wright, E.

13

Review of long‐term complications and functional outcomes of ileoanal pouch procedures in patients with inflammatory bowel disease

enthalten in: ANZ Journal of Surgery | 2023

von Hassan, Y. | Connell, W. | Rawal, A. | +1

14

Non-invasive Serological Monitoring for Crohn's Disease Postoperative Recurrence

enthalten in: Journal of Crohn's & colitis | 2022

von Hamilton, A. | De Cruz, P. | Wright, E. | +3

15

Preconception, antenatal and postpartum management of inflammatory bowel disease

enthalten in: Australian journal of general practice | 2022

von Prentice, R. | Wright, E. | Flanagan, E. | +3

16

Combination tacrolimus and ustekinumab therapy is effective in inducing clinical, biochemical and endoscopic remission in refractory moderate to severe ulcerative colitis

enthalten in: Autoimmunity reviews | 2022

von Gupta, R. | Schulberg, J. | Niewiadomski, O. | +1

CommentOn: Autoimmun Rev. 2021 Jun;20(6):102832. - PMID 33866066

17

Intensive drug therapy versus standard drug therapy for symptomatic intestinal Crohn's disease strictures (STRIDENT) : an open-label, single-centre, randomised controlled trial

enthalten in: The lancet. Gastroenterology & hepatology | 2022

von Schulberg, J. | Wright, E. | Holt, B. | +15

18

Ustekinumab levels in pregnant women with inflammatory bowel disease and infants exposed in utero

enthalten in: Alimentary pharmacology & therapeutics | 2022

von Flanagan, E. | Prentice, R. | Wright, E. | +9

CommentIn: Aliment Pharmacol Ther. 2022 Feb;55(4):495-496. - PMID 35092058

19

The Use of Fecal Calprotectin and Intestinal Ultrasound in the Evaluation and Management of Stricturing Crohn's Disease in Pregnancy

enthalten in: Inflammatory bowel diseases | 2022

von Prentice, R. | Wright, E. | Flanagan, E. | +2

20

Ustekinumab levels in pregnant women with inflammatory bowel disease and infants exposed in utero

enthalten in: Alimentary Pharmacology & Therapeutics | 2022

von Flanagan, E. | Prentice, R. | Wright, E. | +9